The Effect of Electroacupuncture on Obesity

April 9, 2010 updated by: Kyunghee University Medical Center

The Effect of Low Frequency Electroacupuncture on Waist Circumference in Obesity-Three Arm Randomized Controlled Trial, Pilot Study

The purpose of this study is to determine whether electroacupuncture is effective on waist circumference in obesity.

Study Overview

Detailed Description

Many studies have reported on the beneficial effects of acupuncture for obesity, although some negative reports also existed.(Wang F. et al. 2008)Recently conducted systematic review of Pittler and Ernst reported that there was insufficient, but not conclusive evidence to support the efficacy of acupuncture and acupressure for weight loss. However, most of these studies had methodological limitation, such as lack of adequate control group or unclear specific effect of electroacupuncture alone because auricular acupuncture was administered as well. In this sudy, we had three-arm randomized controlled trial(with sham control group) to investigate whether electroacupuncture is effective in the treatment of obesity.

Study Type

Interventional

Enrollment (Anticipated)

39

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hoegi-dong, Dongdaemun-gu
      • Seoul, Hoegi-dong, Dongdaemun-gu, Korea, Republic of, 130-702
        • Kyunghee University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 65 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Waist circumference: Male>= 90 cm, Female >= 85 cm
  • BMI over than 25kg/m2

Exclusion Criteria:

  • Secondary obesity caused by endocrine disease, e.g., polycystic ovary syndrome, diabetes mellitus, Cushing's syndrome, hypothyroidism etc.
  • Heart disease,e.g.,arrhythmia, heart failure, myocardial infarction, and patient with pacemaker
  • Hypertension, hyperlipidemia or hypercholesterinemia patients on medication
  • Stroke or otherwise unable to exercise
  • Pregnant or lactating women
  • Childbirth within 6 months
  • Management for weight control within 3 months
  • Any other conditions deemed unsuitable for trial as evaluated by the physician-in-charge

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Electroacupuncture
The Electroacupuncture therapy protocol included a total of 12 acupuncture points at the CV12,CV6, bilateral ST25, SP15, SP14,LI4, LI11, ST36, ST44. All acupuncture points were prepared with 70% alcohol pads, and disposable stainless steel needles were used. Abdominal acupuncture points were inserted horizontally 6~6.5cm in depth and the others were inserted vertically 2~2.5cm in depth until patient can feel De-Qi. All acupuncture points were stimulated electrically with a frequency of 24 Hz an intensity of 0.27-1.3mA(tolerable strength) with continuous stimulation by the pulse generator. The participants were given treatment twice a week for 30 minutes for 5 weeks by practitioner who had had 6 years of acupuncture training and 3 more years of clinical experience.
We used Electrical stimulator(STN-111,Stratek)with a frequency of 24 Hz and intensity of 0.27-1.3mA(tolerable strength), asymmetric interactive pulse with continuous stimulation by the pulse generator. The participants were given treatment twice a week for 30 minutes for 5 weeks(10 sessions) by practitioner.(n=13)
Other Names:
  • EA group
SHAM_COMPARATOR: Sham electroacupuncture procedure
The Sham electroacupuncture therapy protocol(Non-acupoint, No electrical stimulation)included the same number and type of needle, duration, frequency of sessions and practitioner as for the EA treatment, but superficially at non acupuncture points 15 mm to the lateral of each acupuncture point was treated. The points were not stimulated electrically, but the sound of the pulse generator was heard by the participants. (Lee SH, LeeBC 2009) Those receiving EA or SEA therapy were treated on alternate days to prevent crosstalk among groups, which could have compromised the blinded study design.
We used same electroacupuncture device, number and type of needle, duration, frequency of sessions and practitioner as for the EA treatment. Specific details are as described in the arm description.(n=13)
Other Names:
  • Sham EA group
NO_INTERVENTION: Waiting list
No treatment was done for waiting group, but could receive same treatments as Electroacupuncture group after the end of trial.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
waist circumference
Time Frame: At 5 weeks (post treatment)
At 5 weeks (post treatment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thickness of abdominal subcutaneous fat
Time Frame: Study Day 1 (Baseline)
Thickness of abdominal subcutaneous fat was measured by digital skinfold caliper(FatTrack).
Study Day 1 (Baseline)
Thickness of abdominal subcutaneous fat
Time Frame: At 3weeks
Thickness of abdominal subcutaneous fat was measured by digital skinfold caliper(FatTrack).
At 3weeks
Thickness of abdominal subcutaneous fat
Time Frame: At 5weeks (post treatment)
Thickness of abdominal subcutaneous fat was measured by digital skinfold caliper(FatTrack).
At 5weeks (post treatment)
Thickness of abdominal subcutaneous fat
Time Frame: At 8weeks after first treatment (follow up)
Thickness of abdominal subcutaneous fat was measured by digital skinfold caliper(FatTrack).
At 8weeks after first treatment (follow up)
Waist hip ratio
Time Frame: Study Day 1 (Baseline)
Study Day 1 (Baseline)
Waist hip ratio
Time Frame: At 3weeks
At 3weeks
Waist hip ratio
Time Frame: At 5weeks (post treatment)
At 5weeks (post treatment)
Waist hip ratio
Time Frame: At 8weeks after first treatment (follow up)
At 8weeks after first treatment (follow up)
Body Mass Index
Time Frame: Study Day 1 (Baseline)
Body Mass Index was measured by Inbody 720
Study Day 1 (Baseline)
Body Mass Index
Time Frame: At 3weeks
Body Mass Index was measured by Inbody 720
At 3weeks
Body Mass Index
Time Frame: At 5weeks (post treatment)
Body Mass Index was measured by Inbody 720
At 5weeks (post treatment)
Body Mass Index
Time Frame: At 8weeks after first treatment (follow up)
Body Mass Index was measured by Inbody 720
At 8weeks after first treatment (follow up)
Body fat ratio
Time Frame: Study Day 1 (Baseline)
Body fat ratio was measured by Inbody 720
Study Day 1 (Baseline)
Body fat ratio
Time Frame: At 3weeks
Body fat ratio was measured by Inbody 720
At 3weeks
Body fat ratio
Time Frame: At 5weeks (post treatment)
Body fat ratio was measured by Inbody 720
At 5weeks (post treatment)
Body fat ratio
Time Frame: At 8weeks after first treatment (follow up)
Body fat ratio was measured by Inbody 720
At 8weeks after first treatment (follow up)
Visceral Fat Area
Time Frame: Study Day 1 (Baseline)
Visceral Fat Area was measured by Inbody 720
Study Day 1 (Baseline)
Visceral Fat Area
Time Frame: At 3weeks
Visceral Fat Area was measured by Inbody 720
At 3weeks
Visceral Fat Area
Time Frame: At 5weeks (post treatment)
Visceral Fat Area was measured by Inbody 720
At 5weeks (post treatment)
Visceral Fat Area
Time Frame: At 8weeks after first treatment (follow up)
Visceral Fat Area was measured by Inbody 720
At 8weeks after first treatment (follow up)
Body weight
Time Frame: Study Day 1 (Baseline)
Body weight was measured by Inbody 720
Study Day 1 (Baseline)
Body weight
Time Frame: At 3weeks
Body weight was measured by Inbody 720
At 3weeks
Body weight
Time Frame: At 5weeks (post treatment)
Body weight was measured by Inbody 720
At 5weeks (post treatment)
Body weight
Time Frame: At 8weeks after first treatment (follow up)
Body weight was measured by Inbody 720
At 8weeks after first treatment (follow up)
Obesity degree
Time Frame: Study Day 1 (Baseline)
Obesity degree was measured by Inbody 720
Study Day 1 (Baseline)
Obesity degree
Time Frame: At 3weeks
Obesity degree was measured by Inbody 720
At 3weeks
Obesity degree
Time Frame: At 5weeks (post treatment)
Obesity degree was measured by Inbody 720
At 5weeks (post treatment)
Obesity degree
Time Frame: At 8weeks after first treatment (follow up)
Obesity degree was measured by Inbody 720
At 8weeks after first treatment (follow up)
Bulimia Test Revised
Time Frame: Study Day 1 (Baseline)
Study Day 1 (Baseline)
Bulimia Test Revised
Time Frame: At 5weeks (post treatment)
At 5weeks (post treatment)
Korean version of Obesity-related QOL scale
Time Frame: Study Day 1 (Baseline)
Study Day 1 (Baseline)
Korean version of Obesity-related QOL scale
Time Frame: At 5weeks (post treatment)
At 5weeks (post treatment)
Body Shape Questionnaire
Time Frame: Study Day 1 (Baseline)
Study Day 1 (Baseline)
Body Shape Questionnaire
Time Frame: At 5weeks (post treatment)
At 5weeks (post treatment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sung Keel Kang, Doctor, Kyunghee University Medical Center Oriental Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (ANTICIPATED)

May 1, 2010

Study Completion (ANTICIPATED)

May 1, 2010

Study Registration Dates

First Submitted

April 6, 2010

First Submitted That Met QC Criteria

April 9, 2010

First Posted (ESTIMATE)

April 12, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

April 12, 2010

Last Update Submitted That Met QC Criteria

April 9, 2010

Last Verified

September 1, 2009

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Electroacupuncture

3
Subscribe